Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting
H. Whittaker (London, United Kingdom), H. Mullerova (London, United Kingdom), D. Jarvis (London, United Kingdom), N. Barnes (London, United Kingdom), P. Jones (London, United Kingdom), C. Compton (London, United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Whittaker (London, United Kingdom), H. Mullerova (London, United Kingdom), D. Jarvis (London, United Kingdom), N. Barnes (London, United Kingdom), P. Jones (London, United Kingdom), C. Compton (London, United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom). Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting. 1163
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: